These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 396053)
21. [Therapeutic field trial with praziquantel in a rural population in Mali infected with Schistosoma mansoni (author's transl)]. Ranque P; Konate S; Karemberi B; Kone D Arzneimittelforschung; 1981; 31(3a):597-8. PubMed ID: 7195254 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium. Taylor P; Murare HM; Manomano K J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306 [TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. N'Goran EK; Utzinger J; Gnaka HN; Yapi A; N'Guessan NA; Kigbafori SD; Lengeler C; Chollet J; Shuhua X; Tanner M Am J Trop Med Hyg; 2003 Jan; 68(1):24-32. PubMed ID: 12556143 [TBL] [Abstract][Full Text] [Related]
24. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. Borrmann S; Szlezák N; Faucher JF; Matsiegui PB; Neubauer R; Binder RK; Lell B; Kremsner PG J Infect Dis; 2001 Nov; 184(10):1363-6. PubMed ID: 11679932 [TBL] [Abstract][Full Text] [Related]
25. Phase III clinical trials with praziquantel in S. japonicum infections in the Philippines. Santos AT; Blas BL; Portillo G; Noseñas JS; Poliquit O; Papasin M Arzneimittelforschung; 1984; 34(9B):1221-3. PubMed ID: 6391506 [TBL] [Abstract][Full Text] [Related]
26. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549 [TBL] [Abstract][Full Text] [Related]
27. A pilot control trial of schistosomiasis in central Liberia by mass chemotherapy of target populations, combined with focal application of molluscicide. Saladin B; Saladin K; Holzer B; Dennis E; Hanson A; Degrémont A Acta Trop; 1983 Sep; 40(3):271-95. PubMed ID: 6138977 [TBL] [Abstract][Full Text] [Related]
28. Single dose oral treatment in urinary schistosomiasis: a double blind trial. Pugh RN; Teesdale CH Br Med J (Clin Res Ed); 1983 Feb; 286(6363):429-32. PubMed ID: 6401550 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of praziquantel against Schistosoma haematobium infection in children. Tchuenté LA; Shaw DJ; Polla L; Cioli D; Vercruysse J Am J Trop Med Hyg; 2004 Dec; 71(6):778-82. PubMed ID: 15642971 [TBL] [Abstract][Full Text] [Related]
30. High efficacy of praziquantel in the treatment of 22 patients with Clonorchis/Opisthorchis infections. Horstmann RD; Feldheim W; Feldmeier H; Dietrich M Tropenmed Parasitol; 1981 Sep; 32(3):157-60. PubMed ID: 7345680 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of praziquantel treatment of schistosomiasis in a non-endemic country: a follow-up of parasitological, clinical and immunological parameters. Giboda M; Loudová J; Shonová O; Boucková E; Horácek J; Numrich P; Ruppel A; Vítovec J; Lukes S; Noll P J Hyg Epidemiol Microbiol Immunol; 1992; 36(4):346-55. PubMed ID: 1300350 [TBL] [Abstract][Full Text] [Related]
32. Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with schistosomiasis mansoni. Branchini ML; Pedro Rde J; Dias LC; Deberaldini ER Rev Inst Med Trop Sao Paulo; 1982; 24(5):315-21. PubMed ID: 6762635 [No Abstract] [Full Text] [Related]
33. [Sensitivity of a strain of Schistosoma intercalatum from Loum (Cameroon) and is natural hybrid to treatment with praziquantel. Preliminary results]. Deniau M; Eben-Moussi E; Koki Ndombo P; Same-Ekobo A; Ripert C Arzneimittelforschung; 1981; 31(3a):589-91. PubMed ID: 7195251 [TBL] [Abstract][Full Text] [Related]
34. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum. Zinyowera S; Muchaneta-Kubara CE; Mutapi F; Midzi N; Ndlovu PD; Mduluza T Cent Afr J Med; 2006; 52(9-12):104-11. PubMed ID: 20353134 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of metrifonate in urinary schistosomiasis in light and heavy infections. Feldmeier H; Doehring E; Daffalla AA; Omer AH; Dietrich M Tropenmed Parasitol; 1982 Jun; 33(2):102-6. PubMed ID: 7051495 [TBL] [Abstract][Full Text] [Related]
36. Dose finding double-blind clinical trial with praziquantel in schistosomiasis japonica patients. Chen MG; Hua XJ; Wang MJ; Xu RJ; Yu CB; Jiang SB Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):228-33. PubMed ID: 3934764 [TBL] [Abstract][Full Text] [Related]
37. Praziquantel compared to niridazole in schistosomiasis intercalatum therapy. Feldmeier H; Zwingenberger K; Steiner A; Dietrich M Tropenmed Parasitol; 1981 Mar; 32(1):39-42. PubMed ID: 7233551 [TBL] [Abstract][Full Text] [Related]
38. A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action. Andrews P Arzneimittelforschung; 1981; 31(3a):538-41. PubMed ID: 7016122 [TBL] [Abstract][Full Text] [Related]
39. Praziquantel: a new schistosomicide against Schistosoma haematobium. McMahon JE; Kolstrup N Br Med J; 1979 Dec; 2(6202):1396-9. PubMed ID: 519476 [TBL] [Abstract][Full Text] [Related]
40. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. Olds GR; King C; Hewlett J; Olveda R; Wu G; Ouma J; Peters P; McGarvey S; Odhiambo O; Koech D; Liu CY; Aligui G; Gachihi G; Kombe Y; Parraga I; Ramirez B; Whalen C; Horton RJ; Reeve P J Infect Dis; 1999 Apr; 179(4):996-1003. PubMed ID: 10068597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]